UHRF1 and kidney neoplasm: Figure 2C shows a representative datum. We also performed immunohistochemistry using the kidney specimens. Staining in kidney tumours was weak compared with bladder tumours (Figure 3A and Supplementary Table 4), although overexpression of UHRF1 at the mRNA level was associated with several characteristics of kidney tumour patients, including 5-year survival rates, pathological staging, and histological grade (Figure 3B and C, Supplementary Table 1).